Management of Abnormal Uterine Bleeding in a Patient “Bridged” with LVAD
Preprint
- 16 October 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background: Mechanical circulatory support significantly improved survival in end-stage heart failure patients. However, this treatment associated with a wide range of complications, including infections, stroke and bleeding. Abnormal uterine bleeding (AUB) is often underreported gynecological disorder in female patients following left ventricular assist device (LVAD) implantation. Case Presentation: A 15-year-old female patient with dilated cardiomyopathy and chronic heart failure with reduced ejection fraction underwent implantation of “Heart Mate 3” as a “bridge” to transplant. After LVAD implantation she had recurrent nosebleeds and AUB complicated with moderate anemia. She frequently admitted to the hospital and then managed with antifibrinolytic medication (Tranexamic acid: 500 mg was administered once a day for 3 days) and blood transfusions. By heart team it was decided to reduce antithrombotic therapy: antiplatelets were discontinued and her INR level was maintained 1.4-1.8. For 2 years prior to HTx LVAD function kept fine on minimized antithrombotic therapy without thromboembolic complications. It was made a multidisciplinary team decision to avoid combined oral contraceptives due to the high risk of thromboembolic complications outweighing the benefits. Twice she underwent urgent laparoscopic surgeries but after all her fertile function remained preserved. Conclusions: LVAD patients should be managed with a multidisciplinary heart team. In case of recurrent bleeding and low-risk of thromboembolic complications reduction of antithrombotic therapy should be considered. A personalized approach is essential to determine whether conservative or surgical management is superior, as it balances evidence-based medicine with individual patient needs, reducing the risks of futile or overly aggressive care. Taking into account the reproductive function, an organ-preserving operation was performed for the subsequent preservation of fertile function. Surgical interventions for gynecological disorders can be safely performed in patients “bridged” with LVAD.Keywords
All Related Versions
This publication has 7 references indexed in Scilit:
- The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year UpdateThe Journal of Heart and Lung Transplantation, 2023
- Benefits of Laparoscopic Surgery for Bleeding Events in Patients with Implantable Left Ventricular Assist Devices during Antithrombotic TherapyGynecology and Minimally Invasive Therapy, 2022
- Risk factors of gynecological bleeding in female patients with left-ventricular assist deviceJournal of Artificial Organs, 2021
- Unusual complications following left ventricular assisted device implantation: case seriesJournal of Cardiothoracic Surgery, 2021
- Bleeding in critical care associated with left ventricular assist devices: pathophysiology, symptoms, and managementHematology-American Society Hematology Education Program, 2019
- Dealing with surgical left ventricular assist device complications2015
- Laparoscopic cholecystectomy in a patient with an implantable left ventricular assist deviceBritish Journal of Anaesthesia, 2008